Comment j'explore ... la controverse a propos de la place de l'hyperglycemie provoquee par voie orale en clinique.

Administration, Oral; Adult; Diabetes Mellitus/diagnosis; Diabetes, Gestational/diagnosis; Disease Progression; Female; Glucose Tolerance Test; Humans; Hypoglycemia/complications/diagnosis; Practice Guidelines as Topic; Pregnancy

Abstract :

[en] The oral glucose tolerance test (OGTT) has been widely used for the diagnosis of diabetes mellitus, gestational diabetes or impaired glucose tolerance. However, since 1997, OGTT is not considered anymore as the first choice test for the diagnosis of diabetes mellitus or impaired glucose tolerance, being replaced by fasting glycaemia. Numerous studies, however, stressed the discrepancies between these two diagnostic approaches, so that OGTT still has defenders as a useful tool to diagnose diabetes. Besides, emphasis has been recently put on both postprandial hyperglycaemia, considered as a major cardiovascular risk factor, and impaired glucose tolerance as a predictor of progression toward overt type 2 diabetes, two parameters well addressed by the OGTT. Thus, even if the place to be reserved to the OGTT is controversial, in our opinion, this test still has a place in clinical biology.

Disciplines :

Laboratory medicine & medical technology
Endocrinology, metabolism & nutrition

Author, co-author :

Luyckx, Françoise ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale

Language :

French

Title :

Comment j'explore ... la controverse a propos de la place de l'hyperglycemie provoquee par voie orale en clinique.

Alternative titles :

[en] How I explore ... the controversy concerning the role of oral glucose tolerance test in clinical practice

Publication date :

2003

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

701-5

Peer reviewed :

Peer reviewed

Additional URL :

http://www.rmlg.ulg.ac.be

Available on ORBi :

since 07 April 2009

Statistics

Number of views

194 (4 by ULiège)

Number of downloads

274 (6 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

National Diabetes Data Group.- Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 1979, 28, 1039-1057.
Luyckx FH, Scheen AJ.- L'hyperglycémie provoquée par voie orale. 2. Etude de l'insulinosécrétion, de l'insulinoré sistance et des hormones de la contre-regulation. Immunoanal Biol Spéc, 2003, 18, 185-190.
Luyckx FH, Scheen AJ.- Comment j'explore ... les anomalies du métabolisme glucidique, de l'insulinosécrétion et de la sensibilité à l'insuline avec une hyperglycémie provoquée par voie orale. Rev Med Liège, 2001, 56, 881-885.
Goldstein DE.- Isn't it time to retire the oral glucose tolerance test for diabetes screening and diagnosis? (Editorial). Diabetes Care, 1998, 21, 1215-1216.
Luyckx FH, Scheen AJ.- L'hyperglycémie provoquée par voie orale. I. De la controverse à un plaidoyer pour sa place en biologie clinique. Immuno-Anal Biol Spec, 2003, 18, 126-132.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.- Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20, 1183-1197.
Davies MJ, Raymond NT, Day JL, et al.- Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabetic Med, 2000, 17, 433-440.
Shaw JE, Zimmet PZ, de Courten M, et al.- Impaired fasting glucose or impaired glucose tolerance. Diabetes Care, 1999, 22, 399-402.
Unwin N, Shaw J, Zimmet P, Alberti KGMM.- Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med, 2002, 19, 708-723.
Alberti KG, Zimmet PZ.- Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med, 1998, 15, 539-553.
World Health Organisation.- Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation, 1999.
Alberti KGMM.- The clinical implications of impaired glucose tolerance. Diabetic Med, 1996, 13, 927-937.
Tuomilehto J, Lindström J, Ericksson JG, et al for the Finnish Diabetes Prevention Study Group.- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 200, 344, 1343-1350.
Diabetes Prevention Program Research Group.- Reduction in the incidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med, 2002, 346, 393-403.
Chiasson J-L, Josse RG, Gomis R, et al for the STOP-NIDDM Trial Research Group.- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 2002, 359, 2072-2077.
Scheen AJ.- Prévention du diabète de type 2 chez le sujet obèse: premiers résultats avec l'orlistat dans l'étude XENDOS. Rev Med Liège, 2002, 57, 617-621.
American Diabetes Association.- Postprandial blood glucose. Diabetes Care, 2001, 24, 775-778.
Haffner SM.- The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev, 1998, 19, 583-592.
Lefèbvre PJ, Scheen AJ.- The postprandial state and risk of cardiovascular disease. Diabetic Med, 1998, 15, S63-S68.
Stern MP, Williams K, Haffner SM.- Identification of individuals at high risk of type 2 diabetes: do we need the oral glucose tolerance test ? Ann Int Med, 2002, 136, 575.
DECODE Study Group. European Diabetes Epidemiology Group.- Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 1999, 354, 617-621.
DECODE Study Group.- Glucose tolerance and cardiovascular mortality: comparison of the fasting and the 2-hour diagnostic criteria. Arch Int Med, 2001, 161, 397-404.
Stern MP, Fatehi P, Williams K, Haffner SM.- Predicting future cardiovascular disease. Do we need the oral glucose tolerance test? Diabetes Care, 2002, 25, 1851-1856.
Davidson MB.- The oral glucose tolerance test is superfluous. Diabetes Care, 2002, 25, 1883-1885.
Tuomilehto J.- A glucose tolerance test is important for clinical practice. Diabetes Care, 2002, 25, 1880-1882.
Temelkova-Kurktschiev TS, Hanefeld M.- Oral glucose tolerance test: to be or not to be performed? Clin Lab, 2002, 48, 143-152.
World Health Organisation Study Group on Diabetes Mellitus.- Technical Report Series n° 727. Geneva: World Health Organisation, 1985.
Ko GT, Chan JC, Woo J, et al.- The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem, 1998, 35, 62-67.
Lefèbvre PJ, Scheen AJ.- Glucose metabolism and the postprandial state. Eur J Clin Invest, 1999, 29, 1-6.
Barr RG, Nathan DM, Meigs JB, Singer DE.- Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med, 2002, 137, 263-272.
Sacks DB, Bruns DE, Glodstein DE, et al.- Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem, 2002, 48, 436-472.
Finch CF, Zimmet PZ, Alberti KGMM.- Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabetic Med, 1990, 7, 603-610.
Stolk RP, Orchard TJ, Grobbee DE.- Why use the oral glucose tolerance test? Diabetes Care, 1995, 18, 1045-1049.
Balkau B, Shipley M, Jarrett RJ, et al.- High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 1998, 21, 360-367.
Perry RC, Baron AD.- Impaired glucose tolerance. Why is it not a disease? Diabetes Care, 1999, 22, 883-885.
Baron AD.- Impaired glucose tolerance as a disease. Am J Cardiol, 2001, 88 (suppl), 16H-19H.
de Veght F, Dekker JM, Stehouwer CD, et al.- The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care, 1998, 21, 1686-1690.
de Veght F, Dekker JM, Jager A, et al.- Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA, 2001, 285, 2109-2113.
Tominaga M, Eguchi H, Manaka H, et al.- Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care, 1999, 22, 920-924.
Lindahl B, Weinehall L, Asplund K, Hallmans G.- Screening for impaired glucose tolerance. Diabetes Care, 1999, 22, 1988-1992.
Scheen AJ, Paquot N, Jandrain B, Lefèbvre PJ.- L'hyperglycémie post-prandiale. I. Physiopathologie, conséquences cliniques et approches diététiques. Rev Med Liège, 2002, 57, 138-141.
Scheen AJ, Letiexhe MR, Geronooz I, et al.- L'hyperglycémie post-prandiale. II. Approches thérapeutiques médicamenteuses. Rev Med Liège, 2002, 57, 196-201.
Lefèbvre PJ, Luyckx AS.- The breakfast tolerance test: a return to physiology ? Diabetes Metab, 1976, 2, 15-19.
Balkau B, Forhan A, Eschwege E.- Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia, 2002, 45, 1224-1229.
Scheen AJ, Luyckx FH.- Le syndrome métabolique: définitions et données épidémiologiques. Rev Med Liège, 2003, 58, 479-484.
Luyckx FH, Scheen AJ.- Exploration et suivi biologique d'un patient obèse. Immunoanal Biol Spéc, 2000, 15, 250-254.
Luyckx F, Scheen AJ, Gielen J, Lefèbvre PJ.- Comment j'explore ... Le syndrome d'insulinorésistance grâce à ses marqueurs biologiques. Rev Med Liège, 1997, 52, 686-691.
Ribeiro-Filho FF, Faria AN, Kohlmann NEB, et al.- Two-hour insulin determinaton improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome. Diabetes Care, 2003, 26, 1725-1730.